Att F - Technical Proposal (Toxicology).docx

RFP 27-XXXXX Toxicology Services Technical Proposal Attachment F Instructions

Supply the requested information in the blue shaded areas and indicate any attachments that have been included. Document all attachments with which section and question they pertain to.

1.0 Mandatory Requirements:

1. What laboratory accreditations does your organization currently hold (such as ABFT, ISO/IEC 17025, or CAP), and can you provide the corresponding certificates?

2. What quality assurance and quality control systems does your laboratory use to ensure compliance with required standards and validated testing methods?

3. What is your organization’s capacity to serve all Indiana county coroners, and how many specimens can you reliably process within typical daily and weekly workloads?

2.0 Qualifications & Experience:

1. What similar toxicology programs has your organization provided for a state health department within the past five years?

2. What similar toxicology programs has your organization provided for a county health department within the past five years?

3. How is your organization structured, and what laboratory infrastructure, staffing, and capacity support your ability to provide toxicology testing?

4. What examples can you provide of partnerships with local entities and state government agencies where you delivered toxicology services or related support?

3.0 Testing Capabilities & Laboratory:

1. What methods, instruments, and analytical techniques does your laboratory use to detect, identify, and quantify drug compounds included in the required testing scope?

2. How many of the analytes listed in the QPA can your laboratory test, and what additional drug compounds do you routinely include in your toxicology services?

3. How does your laboratory monitor emerging substances—such as synthetic fentanyl analogues, cannabinoids, and other psychoactive compounds—and how do you determine when and how updates to the QPA analyte list are implemented, including any costs involved?

4. What is your laboratory’s average turnaround times for screening tests, confirmation tests, and directed confirmation analyses from sample receipt to result delivery?

5. Which analytes in the QPA do you report with measurement uncertainty, and how does your laboratory ensure compliance with the required limits of detection in the analyte table?

6. What is the maximum number of specimens your laboratory can accept in a single shipment, and how do you manage high‑volume or surge testing periods?

4.0 Reporting, Communication, & Documentation

1. How are toxicology results communicated to partners, and what online systems or reporting portals does your organization use for secure data access?

2. What standard report formats does your laboratory provide, and how are these reports delivered to customers (such as online portals, email, or other methods)?

3. How does your organization provide certified documents—including chain‑of‑custody documentation—and expert testimony when requested by county prosecutors or other legal authorities?

4. What is your laboratory’s policy for returning specimens within 90 days of test completion, and how long do you retain specimens and records to meet required standards?

5.0 Operational Support & Service Delivery:

1. What types of technical assistance and training does your organization provide to partners, and can you offer at least two examples of past support activities, including any associated costs?

2. What specimen‑collection materials (such as tube wrap, absorbent sheets, transport bags, seals, boxes, and prepaid shipping labels) does your laboratory supply, and how are shipping logistics managed?

3. How does your laboratory determine pricing for QPA‑listed analytes—whether individually, by grouping, or by tier—and can you directly bill prosecutors or police agencies for testing outside the QPA analyte list?